FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
![]() |
- Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).
- Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related change in adults and pediatric patients.
- FET-PET imaging is recommended in international clinical practice guidelines,...
Read more: FDA Approves Telix's Brain Cancer Imaging Drug Pixclara





